Candel Therapeutics Inc. (NASDAQ: CADL) Stock Information | RedChip

Candel Therapeutics Inc. (NASDAQ: CADL)


$8.0100
-0.7400 ( -6.32% ) 787.4K

Candel Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing and commercializing viral immunotherapies to help patients fight cancer. The company has established two clinical-stage viral immunotherapy platforms based on novel, genetically modified adenovirus and herpes simplex virus (HSV) constructs, respectively.

Market Data


Open


$8.0100

Previous close


$8.7500

Volume


787.4K

Market cap


$389.16M

Day range


$7.9160 - $9.1590

52 week range


$1.1000 - $14.6000

SEC Filings


Form Type Description Pages Date
8-k 8K-related 12 May 30, 2024
ars Annual reports 1 May 30, 2024
def Proxies and info statements 3 May 30, 2024
8-k 8K-related 14 May 23, 2024
8-k 8K-related 15 May 14, 2024
10-q Quarterly Reports 76 May 14, 2024
10-k/a Quarterly Reports 17 Apr 25, 2024
8-k 8K-related 13 Apr 25, 2024
8-k 8K-related 13 Apr 11, 2024
8-k 8K-related 13 Apr 09, 2024

Latest News